Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 2
2010 2
2011 3
2012 3
2013 1
2014 1
2015 4
2016 6
2017 7
2018 5
2019 3
2020 5
2021 7
2022 9
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial.
Ageno W, Bertù L, Bucherini E, Camporese G, Dentali F, Iotti M, Lessiani G, Parisi R, Prandoni P, Sartori M, Visonà A, Bigagli E, Palareti G; RIDTS study group. Ageno W, et al. Among authors: bigagli e. BMJ. 2022 Nov 23;379:e072623. doi: 10.1136/bmj-2022-072623. BMJ. 2022. PMID: 36520715 Free PMC article. Clinical Trial.
Implementation of a centralized pharmacovigilance system in academic pan-European clinical trials: Experience from EU-Response and conect4children consortia.
Terzić V, Levoyer L, Figarella M, Bigagli E, Mercier N, De Gastines L, Gibowski S, Trøseid M, Demotes J, Olsen IC, Hites M, Ader F, Lopez JRA, Mentré F, Espérou H, Costagliola D, Røttingen JA, Poissy J, Rozé JC, Warris A, O'Leary J, Fernandes RM, Assoumou L, Hankard R, Turner MA, Yazdanpanah Y, Diallo A; EU-Response safety group; c4c safety group. Terzić V, et al. Among authors: bigagli e. Br J Clin Pharmacol. 2023 Apr;89(4):1318-1328. doi: 10.1111/bcp.15669. Epub 2023 Feb 8. Br J Clin Pharmacol. 2023. PMID: 36680782 Free article. Review.
Tisochrysis lutea F&M-M36 Mitigates Risk Factors of Metabolic Syndrome and Promotes Visceral Fat Browning through β3-Adrenergic Receptor/UCP1 Signaling.
D'Ambrosio M, Bigagli E, Cinci L, Gencarelli M, Chioccioli S, Biondi N, Rodolfi L, Niccolai A, Zambelli F, Laurino A, Raimondi L, Tredici MR, Luceri C. D'Ambrosio M, et al. Among authors: bigagli e. Mar Drugs. 2023 May 17;21(5):303. doi: 10.3390/md21050303. Mar Drugs. 2023. PMID: 37233497 Free PMC article.
Biomarkers of induced active and passive smoking damage.
Lodovici M, Bigagli E. Lodovici M, et al. Among authors: bigagli e. Int J Environ Res Public Health. 2009 Mar;6(3):874-88. doi: 10.3390/ijerph6030874. Epub 2009 Feb 26. Int J Environ Res Public Health. 2009. PMID: 19440419 Free PMC article. Review.
F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypes.
Branchini A, Morfini M, Lunghi B, Belvini D, Radossi P, Bury L, Serino ML, Giordano P, Cultrera D, Molinari AC, Napolitano M, Bigagli E, Castaman G, Pinotti M, Bernardi F; GePKHIS Study Group of AICE. Branchini A, et al. Among authors: bigagli e. J Thromb Haemost. 2022 Jan;20(1):69-81. doi: 10.1111/jth.15552. Epub 2021 Oct 24. J Thromb Haemost. 2022. PMID: 34626083 Free PMC article.
57 results